Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.190
+0.015 (0.69%)
At close: Dec 20, 2024, 4:00 PM
2.210
+0.020 (0.91%)
After-hours: Dec 20, 2024, 7:33 PM EST
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $431.51 million as of December 20, 2024. Its market cap has increased by 140.13% in one year.
Market Cap
431.51M
Enterprise Value
555.75M
1-Year Change
140.13%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $431.51M, an increase of 111.42%. That is a compound annual growth rate of 6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 431.50M | 26.91% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verve Therapeutics | 436.87M |
| Emergent BioSolutions | 436.72M |
| SIGA Technologies | 430.57M |
| Treace Medical Concepts | 429.85M |
| MaxCyte | 428.78M |
| ProKidney | 425.83M |
| Health Catalyst | 424.11M |
| Sonida Senior Living | 424.01M |